with Active Cancer ► See the article "Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patientswith Newly Diagnosed Cancer" in volume 48 on page 406.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted an editorial in Atrial fibrillation with active or newly diagnosed cancer. Non-vitamin K oral anticoagulants (NOACs) vs. Warfarin was evaluated on Stroke/systemic embolism, all-cause mortality, and major bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: